The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Dopamine in drug abuse and addiction: results from imaging studies and treatment implications
Abstract
The involvement of dopamine in drug reinforcement is well recognized but its role in drug addiction is much less clear. Imaging studies have shown that the reinforcing effects of drugs of abuse in humans are contingent upon large and fast increases in dopamine that mimic but exceed in the intensity and duration those induced by dopamine cell firing to environmental events. In addition, imaging studies have also documented a role of dopamine in motivation, which appears to be encoded both by fast as well as smooth DA increases. Since dopamine cells fire in response to salient stimuli, the supraphysiological activation by drugs is likely to be experienced as highly salient (driving attention, arousal conditioned learning and motivation) and may also reset the thresholds required for environmental events to activate dopamine cells. Indeed, imaging studies have shown that in drug-addicted subjects, dopamine function is markedly disrupted (decreases in dopamine release and in dopamine D2 receptors in striatum) and this is associated with reduced activity of the orbitofrontal cortex (neuroanatomical region involved with salience attribution and motivation and implicated in compulsive behaviors) and the cingulate gyrus (neuroanatomical region involved with inhibitory control and attention and implicated in impulsivity). However, when addicted subjects are exposed to drug-related stimuli, these hypoactive regions become hyperactive in proportion to the expressed desire for the drug. We postulate that decreased dopamine function in addicted subjects results in decreased sensitivity to nondrug-related stimuli (including natural reinforcers) and disrupts frontal inhibition, both of which contribute to compulsive drug intake and impaired inhibitory control. These findings suggest new strategies for pharmacological and behavioral treatments, which focus on enhancing DA function and restoring brain circuits disrupted by chronic drug use to help motivate the addicted subject in activities that provide alternative sources of reinforcement, counteract conditioned responses, enhance their ability to control their drive to take drugs and interfere with their compulsive administration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, addictive substances lead to further blunting of the reward response,180 particularly in the VS.”
From Early life adversity and health-risk behaviors: Proposed psychological and neural mechanisms (2018) · cites this paper as [180]
Citations
Cites
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
Goldstein, R. Z., & Volkow, N. D. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.10.1642 · Cited by 2,667
Self-citationGetting formal with dopamine and reward
Schultz, W. (2002) · Neuron · doi:10.1016/s0896-6273(02)00967-4 · Cited by 2,574
Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine
Ritz, M. C., Lamb, R. J., Goldberg, S. R., & Kuhar, M. J. (1987) · Science · doi:10.1126/science.2820058 · Cited by 2,180
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
The Orbitofrontal Cortex and Reward
Rolls, E. T. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.3.284 · Cited by 1,595
Limbic Activation During Cue-Induced Cocaine Craving
Childress, A. R., Mozley, P. D., McElgin, W., Fitzgerald, J., Reivich, M., & O’Brien, C. P. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.1.11 · Cited by 1,513
Relative reward preference in primate orbitofrontal cortex
Tremblay, L., & Schultz, W. (1999) · Nature · doi:10.1038/19525 · Cited by 1,314
Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex
Volkow, N. D. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.3.318 · Cited by 1,240
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Graham J, Porrino LJ . Neuroanatomical substrates of cocaine self-administration. In: Hammer R (ed) Neurobiology of Cocaine. CRC Press: Boca Raton, FL, 1995 pp 3–14.
- De Wit H, Wise RA . Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine or phenoxybenzamine. Can J Psychol 1977; 31: 195–203. · DOI · Paper page
Cited by
Sorted by citations
Items 101–104 of 104
Imaging resilience and recovery in alcohol dependence
Charlet, K., Rosenthal, A., Lohoff, F. W., Heinz, A., & Beck, A. (2018) · Addiction · doi:10.1111/add.14259 · Cited by 29
McNair, L. F., & Kohlmeier, K. A. (2015) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174414000439 · Cited by 22
Serum BDNF levels increase during early drug withdrawal in alcohol and crack cocaine addiction
Ornell, F., Scherer, J. N., Schuch, J. B., Sordi, A. O., Halpern, S. C., Rebelatto, F. P., Bristot, G., Kapczinski, F., Roglio, V. S., Pechansky, F., et al. (2023) · Alcohol · doi:10.1016/j.alcohol.2023.04.001 · Cited by 9
Volkow, N. D., Wang, G.-J., Begleiter, H., Porjesz, B., Fowler, J. S., Telang, F., Wong, C., Ma, Y., Logan, J., Goldstein, R., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.9.999 · Cited by 2
Self-citation
Metadata
- Authors
- Volkow, N. D., Fowler, J. S., Wang, G.-J., & Swanson, J. M.
- Affiliations
- National Institute on Drug Abuse (US)
- Brookhaven National Laboratory (US)
- University of California, Irvine (US)
- Corresponding author
- Volkow, N D
- Venue
- Molecular Psychiatry
- Published
- 2004-04-06
- Volume
- 9
- Issue
- 6
- Pages
- 557-569
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W1980277133
- Cited by
- 1,101
- References
- 130
- Citations by year
- 2026: 22 · 2025: 32 · 2024: 20 · 2023: 37 · 2022: 34 · 2021: 40 · 2020: 87 · 2019: 39 · 2018: 43 · 2017: 39 · 2016: 69 · 2015: 71 · 2014: 78 · 2013: 55 · 2012: 60
- FWCI
- 3.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Office of National Drug Control Policy
- National Institutes of Health (5r01da009490-08)
- National Institute on Alcohol Abuse and Alcoholism (AA-09481, R01AA009481)
- National Institute on Drug Abuse (DA-06891, DA-09490, DA-06278, R01DA006278, R01DA006891)
- Biological and Environmental Research
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- dopamine, drug addiction, drug reinforcement, motivation, salience, orbitofrontal cortex, cingulate gyrus, dopamine D2 receptor, striatum, impulsivity, inhibitory control, pharmacotherapy, behavior therapy
- MeSH terms
- Attention Deficit Disorder with Hyperactivity, Brain, Child, Dopamine, Humans, Neurons, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review